IMMUNO-PHARMA s.r.o.

Active
IČO 44145004limited liability company (s.r.o.)Founded 2008Košice

Key figures

2 224 326 €+8,4%
Revenue 2025
+10,1%
Average annual growth 2020–2025
01 m2 m3 m202020212022202320242025

Key figures

2025

Summary: IMMUNO-PHARMA s.r.o.

What kind of company is it?

IMMUNO-PHARMA s.r.o. (IČO 44145004) is a limited liability company (s.r.o.). The company was incorporated in 2008 and has existed for 18 years. Registered office according to the register: Košice. Main activity according to the Statistical Office: maloobchod s farmaceutickými výrobkami (SK NACE 4773). Size category by number of employees: 10–19 employees.

Who runs the company and who owns it?

The statutory body has 2 members. According to the register, the company has one shareholder. The registered capital is 5 000 €.

How is the company doing financially?

Revenue for 2025 was 2 224 326 €, up 8,4 % on the previous year (2 051 837 €). From 2020 to 2025, revenue grew by an average of 10,1 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 37 352 € (1,7 % of revenue). The company was profitable in 5 of the 6 reported years. Personnel costs for 2025 were 340 827 €. At the end of 2025 the company had total assets of 710 061 € and equity of 249 061 € (equity ratio 35,1 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 21. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)1 652 0451 829 7711 903 9262 051 8372 224 326
Profit for the reporting year-5 98961 20128 75439 26737 352
Retained earnings of previous periods58 97652 987114 187142 942182 209
Total assets535 044692 419702 284812 293710 061
Total liabilities452 557548 731529 843600 584461 000
Total equity82 487143 688172 441211 709249 061
Calculated dividends00000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a company to see its connections.

100 %directordirectorsole shareholderIMMUNO-PHARMA s.r.o.IMMUNO-PHARMA s.r.o.JKIng. Jaroslav KyprIng. Jaroslav KyprMJIng. Marián Jánoš, MBAIng. Marián Jánoš, MBAPHARMAX HOLDINGSLIMITEDPHARMAX HOLDINGS LIMITED
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements15

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4773)
IMMUNO-PHARMA s.r.o. (IČO 44145004) – revenue 2,2M € | icoprofil.sk